The Stock Exchange of Thailand (SET) will list Bangkok Lab and Cosmetics pcl (BLC), a manufacturer and distributor of modern, herbal and animal medicines, cosmetics, and dietary supplements under its own brands – on June 21 under ticker symbol “BLC”. The company has a market capitalization at its initial public offering (IPO) of THB 6.30 billion (approx. USD 180.88 million).
SET Senior Executive Vice President Manpong Senanarong said that BLC will be listed and start trading on Personal Products & Pharmaceuticals sector, the Consumer Products industry group.
BLC manufactures and distributes medical products under 485 brands including modern and generic drugs with the same active ingredients as those in original drugs or those no longer protected by patent under brands such as DiabeDerm, Glucosa and GASTRO BISMOL. The company’s herbal medicines are also available under various brands including Capsika, KACHANA and Plaivana as well as animal medicines, cosmetics, food supplements, and others. BLC formulates drugs in accordance with the principles of pharmaceutical medicine. It also has a research center that applies new technologies and innovations and conducts research and development to increase the value of its products.
BLC has a paid-up capital of THB 300 million after the IPO with a par value of THB 0.50. The company offered 150 million IPO shares, of which 120 million were newly issued shares and 30 million were existing shares held by Viva Sonata Pte., Ltd. to persons at the…
SET welcomes pharmaceutical company BLC on June 21 – SET News
